Literature DB >> 24014475

Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.

Claudia Cavalluzzo1, Frauke Christ, Arnout Voet, Ajendra Sharma, Brajendra Kumar Singh, Kam Y J Zhang, Eveline Lescrinier, Marc De Maeyer, Zeger Debyser, Erik Van der Eycken.   

Abstract

The integration of the viral DNA into the host genome is one of the essential steps in the HIV replication cycle. This process is mediated by the viral enzyme integrase (IN) and lens epithelium-derived growth factor (LEDGF/p75). LEDGF/p75 has been identified as a crucial cellular co-factor of integration that acts by tethering IN to the cellular chromatin. Recently, circular peptides were identified that bind to the C-terminal domain of IN and disrupt the interaction with LEDGF/p75. Starting from the circular peptides, we identified a short peptidic sequence able to inhibit the LEDGF/p75-IN interaction at low μM concentration through its binding to the IN binding site of LEDGF/p75. This discovery can lead to the synthesis of peptidomimetics with high anti-HIV activity targeting the cellular co-factor LEDGF/p75 and not the viral protein IN.
Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  HIV; LEDGF/p75; integrase, protein-protein interaction; solid phase peptide synthesis; structure-activity relationship

Mesh:

Substances:

Year:  2013        PMID: 24014475     DOI: 10.1002/psc.2543

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  2 in total

1.  Combining in silico and in cerebro approaches for virtual screening and pose prediction in SAMPL4.

Authors:  Arnout R D Voet; Ashutosh Kumar; Francois Berenger; Kam Y J Zhang
Journal:  J Comput Aided Mol Des       Date:  2014-01-21       Impact factor: 3.686

2.  Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

Authors:  Juliet D French; Sharon E Johnatty; Yi Lu; Jonathan Beesley; Bo Gao; Murugan Kalimutho; Michelle J Henderson; Amanda J Russell; Siddhartha Kar; Xiaoqing Chen; Kristine M Hillman; Susanne Kaufmann; Haran Sivakumaran; Martin O'Reilly; Chen Wang; Darren J Korbie; Diether Lambrechts; Evelyn Despierre; Els Van Nieuwenhuysen; Sandrina Lambrechts; Ignace Vergote; Beth Karlan; Jenny Lester; Sandra Orsulic; Christine Walsh; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Keitaro Matsuo; Satoyo Hosono; Jacobus Pisterer; Peter Hillemanns; Toru Nakanishi; Yasushi Yatabe; Marc T Goodman; Galina Lurie; Rayna K Matsuno; Pamela J Thompson; Tanja Pejovic; Yukie Bean; Florian Heitz; Philipp Harter; Andreas du Bois; Ira Schwaab; Estrid Hogdall; Susanne K Kjaer; Allan Jensen; Claus Hogdall; Lene Lundvall; Svend Aage Engelholm; Bob Brown; James M Flanagan; Michelle D Metcalf; Nadeem Siddiqui; Thomas Sellers; Brooke Fridley; Julie Cunningham; Joellen M Schildkraut; Ed Iversen; Rachel Palmieri Weber; Donal Brennan; Andrew Berchuck; Paul Pharoah; Paul Harnett; Murray D Norris; Michelle Haber; Ellen L Goode; Jason S Lee; Kum Kum Khanna; Kerstin B Meyer; Georgia Chenevix-Trench; Anna deFazio; Stacey L Edwards; Stuart MacGregor
Journal:  Oncotarget       Date:  2016-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.